Therefore, the serum level of the thyroid-stimulating hormone (TSH) was >100 mIU/L, increased; the thyroglobulin (Tg) specific tumor marker was 13.2 ng/mL (N.V. < 0.1 ng/mL, undetectable in case of cured patients); the anti-thyroglobulin antibody (anti-Tg) was <10 IU/mL (N.V. < 34 IU/mL). The gene discussed is TG; the disease is neoplasm.